MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
10.85%
Quick Ratio
10.85%
Cash Ratio
9.57%
Debt to Asset Ratio
357.00%
Unit: Thousand (K) dollars
Assets Breakdown
    • Operating lease right-of-use ass...
    • Cash and cash equivalents
    • In-process research and developm...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Convertible loan, current
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
23,952
4,754
8,688
14,756
Prepaid expenses and other current assets
673
1,145
1,508
1,415
Other receivables
2,532
47
472
759
Total current assets
27,157
5,946
10,668
16,930
Restricted cash
4,120
4,120
5,390
5,390
Property and equipment, net
11,230
11,780
12,194
12,560
Operating lease right-of-use asset
32,884
33,395
33,911
39,917
In-process research and development
10,256
10,256
10,256
10,256
Goodwill
3,490
3,490
3,490
3,490
Other assets
813
813
973
973
Total assets
89,950
69,800
76,882
89,516
Accounts payable and accrued liabilities
1,855
1,448
1,705
1,999
Accrued compensation
2,043
2,815
2,191
1,843
Convertible loan, current
163,904
-
-
48,088
Term debt, current
77,580
-
-
82,992
Current portion of operating lease liabilities
4,622
4,593
4,564
4,525
Other current liabilities
195
372
487
503
Total current liabilities
250,199
9,228
8,947
139,950
Convertible loan, non-current
-
254,922
153,860
-
Term debt, non-current
42,024
87,976
103,061
15,240
Operating lease liabilities, net of current portion
25,823
26,183
26,533
26,837
Deferred tax liability
3,077
3,077
3,077
3,077
Total liabilities
321,123
381,386
295,478
185,104
Common stock, 0.01 par value 217,000,000 shares authorized 36,644,703 and 37,145,720 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
371
366
364
362
Additional paid-in capital
311,195
304,928
282,574
281,286
Accumulated deficit
-542,739
-616,880
-501,534
-377,236
Total stockholders' deficit
-231,173
-311,586
-218,596
-95,588
Total liabilities and stockholders' deficit
89,950
69,800
76,882
89,516
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$23,952K (453.42%↑ Y/Y)Other receivables$2,532K (16.79%↑ Y/Y)Prepaid expenses andother current assets$673K (-34.28%↓ Y/Y)Operating leaseright-of-use asset$32,884K (-18.81%↓ Y/Y)Total current assets$27,157K (261.13%↑ Y/Y)Property and equipment,net$11,230K (-11.27%↓ Y/Y)In-process research anddevelopment$10,256K (0.00%↑ Y/Y)Restricted cash$4,120K (-23.56%↓ Y/Y)Goodwill$3,490K (0.00%↑ Y/Y)Other assets$813K (-16.44%↓ Y/Y)Total assets$89,950K (11.34%↑ Y/Y)Accumulated deficit-$542,739K (-54.82%↓ Y/Y)Total liabilities andstockholders' deficit$89,950K (11.34%↑ Y/Y)Total stockholders'deficit-$231,173K (-232.61%↓ Y/Y)Additional paid-in capital$311,195K (10.87%↑ Y/Y)Common stock, 0.01 parvalue 217,000,000...$371K (2.49%↑ Y/Y)Total liabilities$321,123K (113.66%↑ Y/Y)Total currentliabilities$250,199K (108.35%↑ Y/Y)Term debt,non-current$42,024K Operating leaseliabilities, net of current...$25,823K (-4.82%↓ Y/Y)Deferred tax liability$3,077K (0.00%↑ Y/Y)Convertible loan, current$163,904K (390.07%↑ Y/Y)Term debt, current$77,580K (-1.66%↓ Y/Y)Current portion ofoperating lease...$4,622K (202.99%↑ Y/Y)Accrued compensation$2,043K (28.98%↑ Y/Y)Accounts payable andaccrued liabilities$1,855K (20.45%↑ Y/Y)Other currentliabilities$195K (42.34%↑ Y/Y)

Armata Pharmaceuticals, Inc. (ARMP)

Armata Pharmaceuticals, Inc. (ARMP)